Javascript must be enabled to continue!
Electrospray ionization mass spectrometry for the hydrolysis complexes of cisplatin: implications for the hydrolysis process of platinum complexes
View through CrossRef
Non‐enzyme‐dependent hydrolysis of the drug cisplatin is important for its mode of action and toxicity. However, up until today, the hydrolysis process of cisplatin is still not completely understood. In the present study, the hydrolysis of cisplatin in an aqueous solution was systematically investigated by using electrospray ionization mass spectrometry coupled to liquid chromatography. A variety of previously unreported hydrolysis complexes corresponding to monomeric, dimeric and trimeric species were detected and identified. The characteristics of the Pt‐containing complexes were investigated by using collision‐induced dissociation (CID). The hydrolysis complexes demonstrate distinctive and correlative CID characteristics, which provides tools for an informative identification. The most frequently observed dissociation mechanism was sequential loss of NH3, H2O and HCl. Loss of the Pt atom was observed as the final step during the CID process. The formation mechanisms of the observed complexes were explored and experimentally examined. The strongly bound dimeric species, which existed in solution, are assumed to be formed from the clustering of the parent compound and its monohydrated or dihydrated complexes. The role of the electrospray process in the formation of some of the observed ions was also evaluated, and the electrospray ionization‐related cold clusters were identified. The previously reported hydrolysis equilibria were tested and subsequently refined via a hydrolysis study resulting in a renewed mechanistic equilibrium system of cisplatin as proposed from our results. Copyright © 2017 John Wiley & Sons, Ltd.
Title: Electrospray ionization mass spectrometry for the hydrolysis complexes of cisplatin: implications for the hydrolysis process of platinum complexes
Description:
Non‐enzyme‐dependent hydrolysis of the drug cisplatin is important for its mode of action and toxicity.
However, up until today, the hydrolysis process of cisplatin is still not completely understood.
In the present study, the hydrolysis of cisplatin in an aqueous solution was systematically investigated by using electrospray ionization mass spectrometry coupled to liquid chromatography.
A variety of previously unreported hydrolysis complexes corresponding to monomeric, dimeric and trimeric species were detected and identified.
The characteristics of the Pt‐containing complexes were investigated by using collision‐induced dissociation (CID).
The hydrolysis complexes demonstrate distinctive and correlative CID characteristics, which provides tools for an informative identification.
The most frequently observed dissociation mechanism was sequential loss of NH3, H2O and HCl.
Loss of the Pt atom was observed as the final step during the CID process.
The formation mechanisms of the observed complexes were explored and experimentally examined.
The strongly bound dimeric species, which existed in solution, are assumed to be formed from the clustering of the parent compound and its monohydrated or dihydrated complexes.
The role of the electrospray process in the formation of some of the observed ions was also evaluated, and the electrospray ionization‐related cold clusters were identified.
The previously reported hydrolysis equilibria were tested and subsequently refined via a hydrolysis study resulting in a renewed mechanistic equilibrium system of cisplatin as proposed from our results.
Copyright © 2017 John Wiley & Sons, Ltd.
Related Results
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
The seventh in the series of ETP Symposia (see
Rapid Communications in Mass Spectrometry
2012,
26
, ...
Abstract 1490: RAD51C-deficient cancer cells require DNA polymerase zeta to bypass cisplatin-induced lesion
Abstract 1490: RAD51C-deficient cancer cells require DNA polymerase zeta to bypass cisplatin-induced lesion
RAD51C is a RAD51 paralog protein that mediates RAD51 filament formation on single-stranded DNA (ssDNA) in a canonical homologous recombination (HR) pathway. This step is vital for...
The Black Mass as Play: Dennis Wheatley's The Devil Rides Out
The Black Mass as Play: Dennis Wheatley's The Devil Rides Out
Literature—at least serious literature—is something that we work at. This is especially true within the academy. Literature departments are places where workers labour over texts c...
The effects of recombinant klotho in cisplatin‐induced ovarian failure in mice
The effects of recombinant klotho in cisplatin‐induced ovarian failure in mice
AbstractAimTo investigate whether recombinant klotho given concomitantly with cisplatin is effective in preventing cisplatin‐induced ovarian damage.MethodsThirty‐two adult female m...
Abstract 1598: Epigenetic priming using azacitidine improves cisplatin response in diffuse large B-cell lymphoma cell lines via endogenous retroviruses induced viral mimicry
Abstract 1598: Epigenetic priming using azacitidine improves cisplatin response in diffuse large B-cell lymphoma cell lines via endogenous retroviruses induced viral mimicry
Abstract
Background and purpose Although majority of patients with diffuse large B-cell lymphoma (DLBCL) achieve and complete remission after first-line rituximab-CH...
Platinum vs non-platinum chemotherapy for platinum-resistant ovarian cancer: a systematic review and meta-analysis
Platinum vs non-platinum chemotherapy for platinum-resistant ovarian cancer: a systematic review and meta-analysis
Abstract
Background
recurrent ovarian cancer (OC) patients with platinum-free interval (PFI) <6 mo. are usually considered p...
Platinum vs non-platinum chemotherapy for platinum-resistant ovarian cancer: A meta-analysis.
Platinum vs non-platinum chemotherapy for platinum-resistant ovarian cancer: A meta-analysis.
e17551 Background: recurrent ovarian cancer (OC) patients with platinum-free interval (PFI) < 6 mo. are usually considered platinum-resistant and treated with non-platinum chem...
CRTAC1 Enhances the Chemosensitivity of Non-Small Cell Lung Cancer to Cisplatin Via Regulating Ca
<sup>2 </sup>/NFAT/STUB1/Akt1 Axis Induced-Apoptosis
CRTAC1 Enhances the Chemosensitivity of Non-Small Cell Lung Cancer to Cisplatin Via Regulating Ca
<sup>2 </sup>/NFAT/STUB1/Akt1 Axis Induced-Apoptosis
Background: Cisplatin-based dualagent chemotherapy is the preferred first-line chemotherapy for non-small cell lung cancer (NSCLC) patients. Moreover, the sensitivity of patients t...

